BACKGROUND: Adjuvant radiotherapy after breast-conserving surgery (BCS) for breast cancer (BC) is a well-established indication. The risk of ischaemic heart disease after radiotherapy for BC increases linearly with the heart mean dose with no apparent threshold. Radiotherapy to the left breast in deep inspiration breath-hold (DIBH) reduces the dose to the heart. A new linac system with an integrated surface scanner (SS) for DIBH treatments was recently installed in our department. We tested it for potential benefits, safety, patients' acceptance/compliance and associated additional workload. MATERIALS AND METHODS: Twenty consecutive patients following BCS for breast carcinoma of the left side were enrolled in our institutional DIBH protocol. We compared dose to the heart and ipsilateral lung (IL) between plans in DIBH and free breathing (FB) using standard defined parameters: mean dose, maximal dose to a volume of 2 cm(3) (D2 cm (3)), volume receiving ≥ 5 Gy (V5), 10 Gy (V10), 15 Gy (V15) and 20 Gy (V20). Comparison of median calculated dose values was performed using a two-tailed Wilcoxon signed rank test. RESULTS: DIBH was associated with a statistically significant reduction (p < 0.001) in all studied parameters for the heart and the IL. In 16 of 20 patients the heart D2 cm (3) was less than 42 Gy in DIBH. In FB the heart D2 cm (3) was ≥ 42 Gy in 17 of 20 patients. The median daily treatment time was 9 min. CONCLUSION: Radiotherapy of the left breast in DIBH using a SS could easily be incorporated into daily routine and is associated with significant dose reduction to the heart and IL.
BACKGROUND: Adjuvant radiotherapy after breast-conserving surgery (BCS) for breast cancer (BC) is a well-established indication. The risk of ischaemic heart disease after radiotherapy for BC increases linearly with the heart mean dose with no apparent threshold. Radiotherapy to the left breast in deep inspiration breath-hold (DIBH) reduces the dose to the heart. A new linac system with an integrated surface scanner (SS) for DIBH treatments was recently installed in our department. We tested it for potential benefits, safety, patients' acceptance/compliance and associated additional workload. MATERIALS AND METHODS: Twenty consecutive patients following BCS for breast carcinoma of the left side were enrolled in our institutional DIBH protocol. We compared dose to the heart and ipsilateral lung (IL) between plans in DIBH and free breathing (FB) using standard defined parameters: mean dose, maximal dose to a volume of 2 cm(3) (D2 cm (3)), volume receiving ≥ 5 Gy (V5), 10 Gy (V10), 15 Gy (V15) and 20 Gy (V20). Comparison of median calculated dose values was performed using a two-tailed Wilcoxon signed rank test. RESULTS:DIBH was associated with a statistically significant reduction (p < 0.001) in all studied parameters for the heart and the IL. In 16 of 20 patients the heart D2 cm (3) was less than 42 Gy in DIBH. In FB the heart D2 cm (3) was ≥ 42 Gy in 17 of 20 patients. The median daily treatment time was 9 min. CONCLUSION: Radiotherapy of the left breast in DIBH using a SS could easily be incorporated into daily routine and is associated with significant dose reduction to the heart and IL.
Authors: Mirjam E Mast; Loes van Kempen-Harteveld; Mark W Heijenbrok; Yamoena Kalidien; Hans Rozema; Wim P A Jansen; Anna L Petoukhova; Henk Struikmans Journal: Radiother Oncol Date: 2013-09-14 Impact factor: 6.280
Authors: Giorgio Pili; Luca Grimaldi; Christian Fidanza; Elena T Florio; Maria F Petruzzelli; Maria P D'Errico; Cristina De Tommaso; Francesco Tramacere; Francesca Musaio; Roberta Castagna; Maria C Francavilla; Emilio A L Gianicolo; Maurizio Portaluri Journal: Int J Radiat Oncol Biol Phys Date: 2011-02-09 Impact factor: 7.038
Authors: Anke van Mourik; Simon van Kranen; Suzanne den Hollander; Jan-Jakob Sonke; Marcel van Herk; Corine van Vliet-Vroegindeweij Journal: Int J Radiat Oncol Biol Phys Date: 2010-10-08 Impact factor: 7.038
Authors: Mette H Nielsen; Martin Berg; Anders N Pedersen; Karen Andersen; Vladimir Glavicic; Erik H Jakobsen; Ingelise Jensen; Mirjana Josipovic; Ebbe L Lorenzen; Hanne M Nielsen; Lars Stenbygaard; Mette S Thomsen; Susanne Vallentin; Sune Zimmermann; Birgitte V Offersen Journal: Acta Oncol Date: 2013-02-19 Impact factor: 4.089
Authors: Frederick R Bartlett; Ruth M Colgan; Karen Carr; Ellen M Donovan; Helen A McNair; Imogen Locke; Philip M Evans; Joanne S Haviland; John R Yarnold; Anna M Kirby Journal: Radiother Oncol Date: 2013-05-29 Impact factor: 6.280
Authors: Paul McGale; Sarah C Darby; Per Hall; Jan Adolfsson; Nils-Olof Bengtsson; Anna M Bennet; Tommy Fornander; Bruna Gigante; Maj-Britt Jensen; Richard Peto; Kazem Rahimi; Carolyn W Taylor; Marianne Ewertz Journal: Radiother Oncol Date: 2011-08 Impact factor: 6.280
Authors: S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto Journal: Lancet Date: 2011-10-19 Impact factor: 79.321
Authors: S Schönecker; C Heinz; M Söhn; W Haimerl; S Corradini; M Pazos; C Belka; H Scheithauer Journal: Strahlenther Onkol Date: 2016-09-08 Impact factor: 3.621
Authors: Stefanie Corradini; Hendrik Ballhausen; Helmut Weingandt; Philipp Freislederer; Stephan Schönecker; Maximilian Niyazi; Cristoforo Simonetto; Markus Eidemüller; Ute Ganswindt; Claus Belka Journal: Strahlenther Onkol Date: 2017-09-15 Impact factor: 3.621
Authors: Alexander Venjakob; Michael Oertel; Dominik Alexander Hering; Christos Moustakis; Uwe Haverkamp; Hans Theodor Eich Journal: Strahlenther Onkol Date: 2020-10-17 Impact factor: 3.621
Authors: David Krug; René Baumann; Wilfried Budach; Jürgen Dunst; Petra Feyer; Rainer Fietkau; Wulf Haase; Wolfgang Harms; Marc D Piroth; Marie-Luise Sautter-Bihl; Felix Sedlmayer; Rainer Souchon; Frederik Wenz; Rolf Sauer Journal: Radiat Oncol Date: 2017-01-23 Impact factor: 3.481